Literature DB >> 19957233

Multiple endocrine neoplasia type 2: clinical manifestations and management.

Amber L Traugott, Jeffrey F Moley.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19957233     DOI： 10.1007/978-1-4419-0857-5_18

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN： 0927-3042


× No keyword cloud information.
  3 in total

1.  Pheochromocytoma in an 8-year-old patient with multiple endocrine neoplasia type 2A: implications for screening.

Authors:  Kathryn J Rowland; Rebecca D Chernock; Jeffrey F Moley
Journal:  J Surg Oncol       Date:  2013-07-19       Impact factor: 3.454

2.  Integrated DNA-based/biochemical screening for early diagnosis of multiple endocrine neoplasia type 2A (MEN2A).

Authors:  Qin Cui; Wen Wang; Zhenzhen Fu; Xin Shao; Zhihong Zhang; Mei Zhang; Xianxia Ju; Kunlin Wang; Jiawei Chen; Hongwen Zhou
Journal:  J Biomed Res       Date:  2013-02-20

3.  Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study.

Authors:  Louise Vølund Larsen; Delphine Mirebeau-Prunier; Tsuneo Imai; Cristina Alvarez-Escola; Kornelia Hasse-Lazar; Simona Censi; Luciana A Castroneves; Akihiro Sakurai; Minoru Kihara; Kiyomi Horiuchi; Véronique Dorine Barbu; Francoise Borson-Chazot; Anne-Paule Gimenez-Roqueplo; Pascal Pigny; Stephane Pinson; Nelson Wohllk; Charis Eng; Berna Imge Aydogan; Dhananjaya Saranath; Sarka Dvorakova; Frederic Castinetti; Attila Patocs; Damijan Bergant; Thera P Links; Mariola Peczkowska; Ana O Hoff; Caterina Mian; Trisha Dwight; Barbara Jarzab; Hartmut P H Neumann; Mercedes Robledo; Shinya Uchino; Anne Barlier; Christian Godballe; Jes Sloth Mathiesen
Journal:  Endocr Connect       Date:  2020-06       Impact factor: 3.335
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.